Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Atossa Genetics Inc.
Type
Public
Traded as NASDAQ: ATOS
Industry Biotechnology
Founded 2009
Founder Dr. Steven Quay
Headquarters Seattle, Washington
Key people
Dr. Steven Quay (CEO)
Products Breast cancer screening and diagnostic tools
Website www.atossagenetics.com

Atossa Genetics NASDAQ: ATOS is a Seattle-based healthcare firm that specializes in breast health. The company focuses on the development and marketing of diagnostic tests which help determine the risk of breast cancer and responsive treatment programs.

Investment goal date:
Dividends reinvested
Atossa Genetics Inc. ATOS report Q2 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-02-14
--
--
Q3 2017
2017-11-13
--
--
Q2 2017
2017-08-14
0.0000
-0.6400
Q1 2017
2017-05-11
0.0000
-0.4500
Q4 2016
2017-03-16
0.0000
-0.8600
Q3 2016
2016-11-14
0.0000
0.0700
Q2 2016
2016-08-12
0.0000
-0.6000
Q1 2016
2016-05-05
0.0000
-1.0500
Q4 2015
2016-03-30
0.0000
-1.3500
Q3 2015
2015-11-12
0.0000
-2.1000
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Major Shareholders
Name Relationship
Total Shares
Holding stocks
QUAY STEVEN C
19.6500% (4826858)
ATOS / MRNA /
CROSS ALEXANDER D
0.3600% (88866)
ATOS / MRNA /
Remmel H. Lawrence
0.0100% (3126)
ATOS /
% ()